| 000 | 01184 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518100200.0 | ||
| 264 | 0 | _c20201204 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1776-260X | ||
| 024 | 7 |
_a10.1007/s11523-020-00711-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChoi, Jun H | |
| 245 | 0 | 0 |
_aTargeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond. _h[electronic resource] |
| 260 |
_bTargeted oncology _c04 2020 |
||
| 300 |
_a147-162 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aBogenberger, James M | |
| 700 | 1 | _aTibes, Raoul | |
| 773 | 0 |
_tTargeted oncology _gvol. 15 _gno. 2 _gp. 147-162 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11523-020-00711-3 _zAvailable from publisher's website |
| 999 |
_c30885435 _d30885435 |
||